FDA crackdowns and a shortage of staff in the pharmaceutical industry are making it harder to get controlled substance prescriptions filled. On October 12, 2022, the FDA announced a shortage of instant-release Adderall. Like many companies, Teva pharmaceuticals, the leading manufacturer of generic Adderall, has had trouble hiring people resulting in shortages of medications in pharmacies. The Adderall shortage has led to …